DuoStim IVF for Low Ovarian Reserve: Why Some Clinics Offer Double Stimulation

In a typical IVF cycle, controlled ovarian stimulation is followed by a retrieval. DuoStim involves stimulation and retrieval at different phases of the same menstrual cycle, often with a second phase after the first retrieval. It should not be confused with simply increasing the drug dose in one stimulation period. The exact drugs, timing and laboratory plan differ by case and by clinical practice. Because eggs must be retrieved twice if both phases proceed, the approach includes repeated procedures and careful monitoring.

A specialist may consider the strategy when previous cycles produced few eggs, when preserving fertility under time pressure or in other selected circumstances. An individual discussion should account for age, AMH, antral follicle count, previous stimulation response, health and treatment goals. Low AMH alone is not sufficient justification. Ask why this approach is preferable to a conventional cycle followed by another cycle later, and whether the clinic’s recommendation is based on evidence relevant to the patient’s situation.

Counting retrieved eggs is easy; explaining whether the strategy improves the chance of a baby is more complex. Patients should ask whether outcome claims refer to mature eggs, blastocysts, embryos suitable for transfer, time to retrieval or live births. Published findings and patient selection vary, and no technique can reverse the age-related biology of individual eggs. A marketing chart that compares two retrievals with one retrieval without accounting for differences in treatment exposure can mislead. Ask to see the denominator and the follow-up period.

Two stimulation phases may mean more medicines, blood tests, ultrasounds and potentially two anaesthesia or sedation events. Discuss how the clinic assesses ovarian response and complication risks, what happens if few follicles develop, and whether a second phase may be cancelled. The patient should receive written medication instructions and emergency contacts. Home injection support, where available, does not remove the need for proper monitoring or facility-based retrieval and embryo laboratory work.

Request itemised costs for both retrievals, medication in each phase, laboratory insemination, culture, freezing, storage and subsequent transfer. Ask which charges are refundable or payable even when a retrieval yields no egg. Alternatives may include a standard stimulation protocol, time for medical review, or other reproductive options where appropriate. The most aggressive plan is not necessarily the best-value plan. Emotional, physical and financial capacity belong in the consent process.

HomeIVF aims to reduce avoidable clinic visits by coordinating fertility care under medical supervision. Teleconsultation can help patients understand why DuoStim is proposed and review records between phases. Some prescribed injection assistance and blood collection may be possible at home only after serviceability and suitability are verified. Every required ultrasound, both retrieval procedures if undertaken, embryology steps and embryo transfers remain in appropriate clinical facilities. A remote service cannot certify that a second retrieval is necessary.

Ask your clinician to write down the working diagnosis, which evidence supports it, the treatment options discussed and what result would actually change the plan. Confirm whether both partners have been appropriately assessed, what tests are necessary rather than merely available, who reviews time-sensitive findings and what happens when a cycle does not go as hoped. Request a complete estimate of investigation, medication, monitoring, facility and laboratory charges. Decisions should be framed as informed choices under uncertainty rather than sales deadlines or promised success.

HomeIVF is a doctor-led, home-supported fertility-care model intended to reduce unnecessary clinic visits rather than replace clinical IVF. Depending on medical needs and confirmed local availability, teleconsultations, selected home blood collection and help administering prescribed injections may be possible. None is promised for every patient or location. Required ultrasounds and examinations, clinical IUI, sperm retrieval, egg retrieval, embryology and embryo transfer must take place in appropriate facilities. Home services must follow the treating clinician’s orders and the laboratory’s timing and quality requirements. A patient with urgent symptoms needs an appropriate emergency service, not an online appointment.